Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin in...
Leadership
Troy Edward Wilson J.D., Ph.D.
Chairman, CEO & President
Kathleen Ford
Chief Operating Officer
Brian T. Powl M.B.A., M.S.
Chief Commercial Officer
Thomas Doyle
Senior Vice President of Finance & Accounting
Francis J. Burrows Ph.D.
Chief Scientific Officer
Greg Mann
Senior Vice President of Investor Relations & Corporate Affairs
Teresa Brophy Bair Esq., J.D.
Chief Legal Officer & Corporate Secretary
Roger Bakale Ph.D.
Senior Vice President of Manufacturing & Supply Chain
Mollie Leoni M.D.
Chief Medical Officer
Samir Vattompadam M.S.
Senior Vice President of Global Program Leadership
